Lys211

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Ubiquitylation Site Page: > Lys211 - CASP9 (human)

Site Information
kGDLtAkkMVLALLE SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 150180306

In vivo Characterization
Methods used to characterize site in vivo:	immunoprecipitation ( 1 ) , mass spectrometry ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:	esophageal cancer ( 1 ) , esophageal carcinoma ( 1 )
Relevant cell line - cell type - tissue:	Kyse30 (esophageal) ( 1 )

References
1	Li Y, et al. (2017) The E3 ligase HECTD3 promotes esophageal squamous cell carcinoma (ESCC) growth and cell survival through targeting and inhibiting caspase-9 activation. Cancer Lett 404, 44-52 28716524 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.